Enestebol

Enestebol is a synthetic androgen and anabolic steroid (AAS) which was never marketed. It is also known as 17α-ethyl-19-nortestosterone or as 17α-ethylestr-4-en-17β-ol-3-one, and is a 17α-alkylated derivative of 19-nortestosterone (nandrolone).

History

Enestebol was first described in the scientific literature in 1966. It was developed by the pharmaceutical company Organon, but was never marketed.

Pharmacology

As an AAS, enestebol is a agonist of the androgen receptor (AR), similarly to androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and weak androgenic effects, which give it a favorable anabolic-to-androgenic ratio.

Chemistry

Enestebol, also known as 17α-ethyl-19-nortestosterone or as 17α-ethylestr-4-en-17β-ol-3-one, is a synthetic estrane steroid and a derivative of testosterone. It is more specifically a derivative of 19-nortestosterone (nandrolone) and is a member of the 17α-alkylated family of AAS.

See also

• List of androgen esters
• List of androgens/anabolic steroids

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian